bone marrow transplant
Showing 76 - 100 of >10,000
Recurrent Acute Myeloid Leukemia Trial in Nashville (Venetoclax, Decitabine, Cedazuridine)
Not yet recruiting
- Recurrent Acute Myeloid Leukemia
- Venetoclax
- +4 more
-
Nashville, TennesseeVanderbilt University/Ingram Cancer Center
Mar 22, 2023
Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (procedure, drug,
Not yet recruiting
- Acute Leukemia of Ambiguous Lineage
- +8 more
- Biospecimen Collection
- +12 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Aug 22, 2023
AL Amyloidosis Trial (procedure, drug, other)
Not yet recruiting
- AL Amyloidosis
- Autologous Hematopoietic Stem Cell Transplantation
- +15 more
- (no location specified)
Aug 28, 2023
GI Cancer, Lymphoma, GU Cancer Trial in New York (Self-Efficacy Assessment, UCLA Geriatrics Attitudes Scale, Course Evaluations)
Active, not recruiting
- GI Cancer
- +3 more
- Self-Efficacy Assessment
- +5 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Mar 16, 2022
Intravenous Acyclovir in Oncologic Paediatric Patients
Active, not recruiting
- Herpesviridae Infections
- +4 more
- Pharmacokinetic analysis
-
Trieste, TS, ItalyIRCCS Burlo Garofolo, Bone Marrow Transplant Unit, Institute for
Jan 19, 2022
Blood Disorders Trial in Durham (Patient-Centered Medical Home (PCMH), Standard Care)
Recruiting
- Blood Disorders
- Patient-Centered Medical Home (PCMH)
- Standard Care
-
Durham, North CarolinaDuke University Adult Bone Marrow Transplant Clinic
Sep 16, 2021
Disorder Related to Bone Marrow Transplantation, Leukemia, Transplantation Infection Trial in Houston (Fludarabine, Clofarabine,
Completed
- Disorder Related to Bone Marrow Transplantation
- +2 more
- Fludarabine
- +6 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Nov 18, 2021
Sickle Cell Disease Trial in United States (Busulfan, Fludarabine, r-ATG)
Active, not recruiting
- Sickle Cell Disease
- Busulfan
- +11 more
-
Oakland, California
- +34 more
Sep 21, 2022
Hematologic Malignancy, Bone Marrow Transplant Trial in New York (Tocilizumab, Fludarabine, Melphalan)
Recruiting
- Hematologic Malignancy
- Bone Marrow Transplant
- Tocilizumab
- +4 more
-
New York, New YorkWeill Cornell Medical College
Oct 27, 2021
Bone Marrow Transplant Complications, Sinusoidal Obstruction Syndrome, Veno Occlusive Disease, Hepatic Trial in Kansas City
Recruiting
- Bone Marrow Transplant Complications
- +3 more
- Ultrasound Elastography
-
Kansas City, MissouriAmie Robinson
Oct 26, 2021
Congenital Hemolytic Anemia, Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Peripheral
Recruiting
- Congenital Hemolytic Anemia
- Sickle Cell Disease
- Peripheral blood hematopoietic progenitor cell (PBPC) transplant
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Allogeneic Stem Cell Transplantation in Elderly: 17-years
Completed
- Allogeneic Stem Cell Transplantation in Elderly Patients
-
Brescia, ItalyChair of Hematology and Bone marrow Transplant Unit
Jul 21, 2021
Hematologic Malignancy, Myeloid Malignancy Trial in Memphis (Ruxolitinib, Mesna, Anti-thymocyte globulin (ATG))
Recruiting
- Hematologic Malignancy
- Myeloid Malignancy
- Ruxolitinib
- +10 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
Nov 7, 2022
Myeloproliferative Disorders, Acute Myelogenous Leukemia, Chronic Myelogenous Leukemia Trial run by the NHLBI (T-cell replete
Completed
- Myeloproliferative Disorders
- +4 more
- T-cell replete PBPC allograft
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 12, 2022
Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, MDS Trial in Saint Louis (procedure, drug, other)
Recruiting
- Acute Myelogenous Leukemia
- +4 more
- Stem cell transplantation
- +3 more
-
Saint Louis, MissouriWashington University School of Medicine
Aug 23, 2022
Viral Infections, Bone Marrow Transplant Infection Trial in Washington (Virus Specific T cells (VSTs))
Recruiting
- Viral Infections
- Bone Marrow Transplant Infection
- Virus Specific T cells (VSTs)
-
Washington, District of ColumbiaChildrens National Medical Center
Oct 12, 2021
Leukemia Trial (biological, drug, procedure, radiation)
Active, not recruiting
- Leukemia
- aldesleukin
- +9 more
- (no location specified)
Feb 17, 2022
Solid Organ Transplant Rejection, Organ Rejection Transplants, Organ Rejection Trial (Bone Marrow Mesenchymal Stem Cell Derived
Not yet recruiting
- Solid Organ Transplant Rejection
- +2 more
- Bone Marrow Mesenchymal Stem Cell Derived Extracellular Vesicles Infusion Treatment
- (no location specified)
Aug 16, 2022
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Chronic Myeloid Leukemia Trial in San Francisco (CD34+ enriched, T Cell
No longer available
- Acute Lymphoblastic Leukemia
- +11 more
- CD34+ enriched, T Cell Depleted donor stem cell product
-
San Francisco, CaliforniaUniversity of California, San Francisco
May 25, 2021
Myeloablative Conditioning, HLA-mismatched Bone Marrow Transplantation, Graft Survival Trial in Canada, United States (drug,
Completed
- Myeloablative Conditioning
- +3 more
- Cyclophosphamide
- +5 more
-
Aurora, Colorado
- +8 more
Nov 23, 2021
Oral Mucositis, Bone Marrow Transplant Complications Trial in Gdansk (Laser therapy)
Completed
- Oral Mucositis
- Bone Marrow Transplant Complications
- Laser therapy
-
Gdańsk, Pomeranian, PolandMedical University of Gdańsk
Dec 30, 2021
AML, ALL, MDS Trial in New York (Clofarabine, Fludarabine, Busulfan)
Recruiting
- AML
- +8 more
- Clofarabine
- +5 more
-
New York, New YorkMemorial Sloan Kettering Cancer Center
May 13, 2022
Tumors, Bone Marrow Transplantation Trial in Parkville (Release of Extended Pharmacogenomics Report at Week 1, Release of
Not yet recruiting
- Neoplasms
- Bone Marrow Transplantation
- Release of Extended Pharmacogenomics Report at Week 1
- Release of Extended Pharmacogenomics Report at Week 13
-
Parkville, Victoria, AustraliaThe Royal Children's Hospital
Dec 19, 2022
Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia, Biphenotypic Acute Leukemia Trial in Minneapolis (biological, drug,
Not yet recruiting
- Acute Myelogenous Leukemia
- +17 more
- Peripheral Blood Stem Cell Transplant
- +7 more
-
Minneapolis, MinnesotaMasonic Cancer Center at University of Minnesota
Mar 27, 2023